Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

China flag China · Delayed Price · Currency is CNY
6.92
+0.01 (0.14%)
Apr 29, 2026, 3:00 PM CST
Market Cap4.79B +12.0%
Revenue (ttm)2.20B -13.1%
Net Income319.41M +34.4%
EPS0.46 +38.1%
Shares Out692.00M
PE Ratio15.08
Forward PEn/a
Dividend0.40 (5.79%)
Ex-Dividend DateFeb 6, 2026
Volume27,198,870
Average Volume26,861,476
Open6.87
Previous Close6.91
Day's Range6.81 - 6.93
52-Week Range5.86 - 8.68
Beta0.11
RSI59.46
Earnings DateApr 25, 2026

About SHA:600351

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China. [Read more]

Sector Healthcare
Founded 1978
Employees 3,611
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600351
Full Company Profile

Financial Performance

In 2025, SHA:600351's revenue was 2.24 billion, a decrease of -16.60% compared to the previous year's 2.69 billion. Earnings were 320.01 million, an increase of 31.86%.

Financial Statements